Skip to main content
Neurology and Therapy logoLink to Neurology and Therapy
. 2023 Jun 27;12(5):1591–1592. doi: 10.1007/s40120-023-00508-2

Correction to: Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO

Antoine Regnault 1, Thomas Morel 2,✉, Christine de la Loge 3, Flora Mazerolle 1, Henry J Kaminski 4, Ali A Habib 5
PMCID: PMC10444721  PMID: 37368226

Correction to: Neurol Ther 10.1007/s40120-023-00464-x

In Fig. 2 of this article the figure label “Body Could not Keep up With” should have appeared as “Body Could not Keep up With What You Wanted to Do”. The corrected Fig. 2 appears below.

Fig. 2.

Fig. 2

Distribution of the responses to the items of the Myasthenia Gravis Symptoms Patient-Reported Outcomes (MG Symptoms PRO) instrument (n = 541 assessments from 43 unique patients). Darker colors in the cell indicate higher percentages of patients who endorsed the response. Item label colors indicate the core MG symptom to which the item relates: blue physical fatigue; purple muscle weakness fatigability; yellow ocular muscle weakness; turquoise bulbar muscle weakness; gray respiratory muscle weakness

The original article has been corrected.

Contributor Information

Antoine Regnault, Email: antoine.regnault@threadresearch.com.

Thomas Morel, Email: Thomas.Morel@ucb.com.

Christine de la Loge, Email: cdelaloge@pcom-analytics.com.

Flora Mazerolle, Email: flora.mazerolle@threadresearch.com.

Henry J. Kaminski, Email: hkaminski@mfa.gwu.edu

Ali A. Habib, Email: aahabib@hs.uci.edu


Articles from Neurology and Therapy are provided here courtesy of Springer

RESOURCES